Animal Parasiticides Market Size and Outlook 2030

Report Description

Forecast Period	2026-2030
Market Size (2024)	USD 10.82 Billion
CAGR (2025-2030)	4.25%
Fastest Growing Segment	Ectoparasiticides
Largest Market	North America
Market Size (2030)	USD 13.89 Billion

Market Overview

The Global Animal Parasiticides Market, valued at USD 10.82 Billion in 2024, is projected to experience a CAGR of 4.25% to reach USD 13.89 Billion by 2030. Animal parasiticides are pharmaceutical agents developed to prevent and treat infections caused by various internal and external parasites in livestock and companion animals. Market growth is primarily driven by the increasing global prevalence of parasitic diseases in both production and companion animals, coupled with a rising demand for safe animal protein. Additionally, heightened awareness among pet owners regarding animal health and the critical role of parasiticides in preventing zoonotic disease transmission further propels market expansion.

The significant impact of parasitic diseases underscores the continuous need for effective solutions. For instance, according to the World Organisation for Animal Health (WOAH), in 2024, 65% of cattle mortality in Zimbabwe was linked to theileriosis and other tickborne parasitic diseases. However, a substantial challenge impeding market expansion involves the ongoing development of drug resistance in various parasite species, necessitating continuous innovation in product development to maintain efficacy.

Key Market Drivers

The increasing prevalence of animal parasitic and zoonotic diseases represents a significant catalyst for the global animal parasiticides market. Parasitic infections in both livestock and companion animals lead to substantial economic losses and pose public health risks due to their zoonotic potential. These diseases diminish animal productivity, cause morbidity and mortality, and necessitate constant vigilance and effective control measures. For example, according to MSD Animal Health, on May 21, 2024, in their article "The Global Economic Impact of Parasites in Cattle", farmers in major cattle producing regions suffer losses exceeding US$21 billion annually due to internal and external parasites. The economic burden from lost production and treatment costs underscores the continuous need for potent parasiticides to protect animal welfare, optimize agricultural output, and safeguard human health from transmitted pathogens.

Complementing this, the rising global pet ownership and humanization trends profoundly influence the demand for animal parasiticides. Pets are increasingly regarded as integral family members, leading owners to prioritize their health and well-being, including preventive parasitic treatments. This shift in perception translates directly into heightened expenditure on veterinary care and pharmaceutical products. According to the American Pet Products Association Inc. , in October 2023, 66% of households in the US owned a type of pet, an increase from 62% in 2022. This growing commitment to pet health fuels the market for parasiticides designed for companion animals. Overall, the significant investment in animal well-being is evident, as according to the 2023-2024 National Pet Owners Survey conducted by the American Pet Products Association, in 2024, Americans were estimated to spend $150 billion on pet care.

Download Free Sample Report

Key Market Challenges

The ongoing development of drug resistance in various parasite species presents a substantial impediment to the growth of the Global Animal Parasiticides Market. As parasites evolve resistance to existing treatments, the efficacy of current pharmaceutical agents diminishes, leading to increased treatment failures in both livestock and companion animals. This directly impacts market expansion by undermining confidence in available products and necessitating continuous, costly research and development efforts to discover and bring to market new active ingredients and formulations. These elevated research and development expenditures and extended development timelines can restrict the introduction of innovative solutions, thereby constraining market supply and profitability. The economic consequences for animal agriculture are significant; for instance, according to a September 2024 report by the World Organisation for Animal Health (WOAH), annual livestock production losses from drug-resistant pathogens could contribute to a cumulative global gross domestic product loss of $575 billion by 2050 under a low-resistance scenario. Such losses to animal health and productivity reduce farmer profitability, which in turn can limit their investment in parasiticidal solutions if product effectiveness is not guaranteed.

Key Market Trends

The ongoing development of drug resistance in various parasite species presents a substantial impediment to the Global Animal Parasiticides Market. As parasites evolve resistance, existing treatments lose efficacy, causing increased treatment failures in both livestock and companion animals. This necessitates continuous, costly research and development for new active ingredients with novel modes of action. For example, according to Merck Animal Health, a division of Merck & Co. , Inc. , in May 2024, farmers in major cattle producing regions face annual losses exceeding US$21 billion from parasites, a problem exacerbated by parasiticide resistance. Such elevated research and development and extended development timelines can constrain innovative solution introduction, impacting market supply and profitability.

Advancements in parasiticide formulations and delivery systems are a pivotal trend, improving treatment efficacy and user convenience. Innovations provide prolonged protection, enhanced palatability for pets, and easier administration for livestock, directly boosting treatment compliance and animal well-being. This trend drives market value by making parasiticides more effective and desirable. For instance, Zoetis, a leading animal health company, reported in its 2023 Annual Report that new product approvals and market expansions, including research and development for new combinations and reformulations, contributed to a 7% operational revenue growth in 2023. Such innovation in product presentation and administration is crucial for expanding market penetration amid rising demand for convenient and highly effective solutions.

Segmental Insights

In the Global Animal Parasiticides Market, the Ectoparasiticides segment is experiencing the most rapid expansion. This accelerated growth is primarily driven by the escalating global prevalence of external parasites such as fleas, ticks, and mites, which pose significant health risks to both companion and livestock animals. Enhanced pet ownership rates, coupled with increased expenditure on animal healthcare, also fuel demand for effective preventive and treatment solutions. Furthermore, a heightened awareness of zoonotic diseases, transmissible from animals to humans, underscores the critical role of ectoparasiticides in public health. Climate change, expanding the geographical range of many ectoparasite species, and continuous advancements in convenient, highly efficacious product formulations further contribute to this robust segmental growth.

Regional Insights

North America leads the Global Animal Parasiticides Market due to its advanced veterinary healthcare infrastructure and a robust regulatory framework that emphasizes animal health and disease prevention. The region benefits from high awareness among pet owners regarding animal wellness, coupled with elevated pet ownership rates and significant expenditure on animal healthcare as pets are increasingly viewed as family members. Additionally, a strong pharmaceutical research and development ecosystem, supported by stringent regulations and the presence of major industry players, drives continuous product innovation and market expansion.

Recent Developments

In August 2025, Merck Animal Health presented new data supporting its BRAVECTO® fluralaner portfolio at the 2025 World Association for the Advancement of Veterinary Parasitology Congress. The presented studies highlighted the company's continuous commitment to advancing research in parasite prevention and treatment for dogs. Key findings included the long-term efficacy of BRAVECTO against specific tick infestations and the successful treatment of demodectic mange and canine roundworm/hookworm infections using combination tablets. This research contributes to expanding the scientific understanding and efficacy of existing parasiticides in the global market.

In February 2025, MSD Animal Health, a division of Merck & Co., Inc., received the 2024 S&P Global Award for Best New Companion Animal Product. This recognition was for their injectable formulation of BRAVECTO® (fluralaner), a significant development in the global animal parasiticides market. This product, which secured approval in the European Union in 2024, is the first and only parasiticide designed to provide dogs with year-round protection against fleas and ticks from a single dose. This extended duration of efficacy surpasses other systemic products available, reinforcing MSD Animal Health's leadership in long-acting preventative parasiticides.

In October 2024, Elanco Animal Health secured FDA approval for its Credelio Quattro chewable tablets, specifically designed for dogs. This new product, comprising lotilaner, moxidectin, praziquantel, and pyrantel, offers broad-spectrum protection against six common parasites, including fleas, ticks, heartworm disease, roundworms, hookworms, and tapeworms. The subsequent U.S. market launch in January 2025 has seen strong demand, indicating a significant contribution to the animal parasiticides market by providing an all-in-one monthly preventive solution that simplifies treatment regimens for pet owners.

In September 2024, Boehringer Ingelheim introduced a new monthly parasiticide solution for cats in the UAE market. This product launch marked a notable advancement in feline healthcare, offering a broad-spectrum defense against both internal and external parasites. The innovative formula integrates three active ingredients: esafoxolaner for fleas and ticks, eprinomectin for internal parasites, and praziquantel for various worms. This comprehensive protection means cats can be shielded from a wide array of parasites with a single application, enhancing convenience for pet owners and veterinarians in the animal parasiticides market.

Key Market Players

Eli Lilly and Company
Merck and Co., Inc.
Vetoquinol S.A.
Oceanic Pharmachem Pvt. Ltd.
Boehringer Ingelheim International GmbH
Intas Pharmaceuticals Ltd.
Erbe Elektromedizin GmbH
Conmed Corporation
Ammega Group BV
KLS Martin LP

By Product Type	By Animal	By End user	By Region
Ectoparasiticides Endectocides Endoparasiticides	Companion animals Food-producing animals	Veterinary hospitals and Clinics Animal farms Home care settings	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Animal Parasiticides Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Parasiticides Market, By Product Type:

o Ectoparasiticides

o Endectocides

o Endoparasiticides

Animal Parasiticides Market, By Animal:

o Companion animals

o Food-producing animals

Animal Parasiticides Market, By End user:

o Veterinary hospitals and Clinics

o Animal farms

o Home care settings

Animal Parasiticides Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ United Kingdom

§ Italy

§ Germany

§ Spain

o Asia Pacific

§ China

§ India

§ Japan

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Animal Parasiticides Market.

Available Customizations:

Global Animal Parasiticides Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Animal Parasiticides Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Parasiticides Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product Type (Ectoparasiticides, Endectocides, Endoparasiticides)

5.2.2. By Animal (Companion animals, Food-producing animals)

5.2.3. By End user (Veterinary hospitals and Clinics, Animal farms, Home care settings)

5.2.4. By Region

5.2.5. By Company (2024)

5.3. Market Map

6. North America Animal Parasiticides Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product Type

6.2.2. By Animal

6.2.3. By End user

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Animal Parasiticides Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product Type

6.3.1.2.2. By Animal

6.3.1.2.3. By End user

6.3.2. Canada Animal Parasiticides Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product Type

6.3.2.2.2. By Animal

6.3.2.2.3. By End user

6.3.3. Mexico Animal Parasiticides Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product Type

6.3.3.2.2. By Animal

6.3.3.2.3. By End user

7. Europe Animal Parasiticides Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product Type

7.2.2. By Animal

7.2.3. By End user

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Animal Parasiticides Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product Type

7.3.1.2.2. By Animal

7.3.1.2.3. By End user

7.3.2. France Animal Parasiticides Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product Type

7.3.2.2.2. By Animal

7.3.2.2.3. By End user

7.3.3. United Kingdom Animal Parasiticides Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product Type

7.3.3.2.2. By Animal

7.3.3.2.3. By End user

7.3.4. Italy Animal Parasiticides Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product Type

7.3.4.2.2. By Animal

7.3.4.2.3. By End user

7.3.5. Spain Animal Parasiticides Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product Type

7.3.5.2.2. By Animal

7.3.5.2.3. By End user

8. Asia Pacific Animal Parasiticides Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product Type

8.2.2. By Animal

8.2.3. By End user

8.2.4. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Animal Parasiticides Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product Type

8.3.1.2.2. By Animal

8.3.1.2.3. By End user

8.3.2. India Animal Parasiticides Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product Type

8.3.2.2.2. By Animal

8.3.2.2.3. By End user

8.3.3. Japan Animal Parasiticides Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product Type

8.3.3.2.2. By Animal

8.3.3.2.3. By End user

8.3.4. South Korea Animal Parasiticides Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product Type

8.3.4.2.2. By Animal

8.3.4.2.3. By End user

8.3.5. Australia Animal Parasiticides Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product Type

8.3.5.2.2. By Animal

8.3.5.2.3. By End user

9. Middle East & Africa Animal Parasiticides Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product Type

9.2.2. By Animal

9.2.3. By End user

9.2.4. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Animal Parasiticides Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product Type

9.3.1.2.2. By Animal

9.3.1.2.3. By End user

9.3.2. UAE Animal Parasiticides Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product Type

9.3.2.2.2. By Animal

9.3.2.2.3. By End user

9.3.3. South Africa Animal Parasiticides Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product Type

9.3.3.2.2. By Animal

9.3.3.2.3. By End user

10. South America Animal Parasiticides Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product Type

10.2.2. By Animal

10.2.3. By End user

10.2.4. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Animal Parasiticides Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product Type

10.3.1.2.2. By Animal

10.3.1.2.3. By End user

10.3.2. Colombia Animal Parasiticides Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product Type

10.3.2.2.2. By Animal

10.3.2.2.3. By End user

10.3.3. Argentina Animal Parasiticides Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product Type

10.3.3.2.2. By Animal

10.3.3.2.3. By End user

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Animal Parasiticides Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Eli Lilly and Company

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Merck and Co., Inc.

15.3. Vetoquinol S.A.

15.4. Oceanic Pharmachem Pvt. Ltd.

15.5. Boehringer Ingelheim International GmbH

15.6. Intas Pharmaceuticals Ltd.

15.7. Erbe Elektromedizin GmbH

15.8. Conmed Corporation

15.9. Ammega Group BV

15.10. KLS Martin LP

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Animal Parasiticides Market in 2024?

Which is the dominating region in the Global Animal Parasiticides Market?

Which is the fastest growing segment in the Global Animal Parasiticides Market?

What is the expected growth rate of the Global Animal Parasiticides Market?